iShares Neuroscience and Healthcare ETF Rating $25.34 -0.37 (-1.44%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.78Holdings in IBRN have an aggregate rating of Moderate Buy based on 393 analyst ratings issued in the past year covering 41 companies (84.2% of the portfolio).IBRN Aggregate Price Target$25.34High Prediction$25.34Average Prediction$25.34Low Prediction$25.34Holdings in IBRN have an aggregate price target of $25.34 and a range of $25.34 to $25.34 covering 41 companies (84.2% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy23 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 41 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.27%ITCIIntra-Cellular Therapies$128.60+0.0%3.8839 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage4.44%ACADACADIA Pharmaceuticals$19.95-1.7%3.0653 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓4.32%SUPNSupernus Pharmaceuticals$33.05-4.5%1.6163 of 5 stars2.33$36.00 8.9%3Analyst DowngradeNews Coverage4.26%CPRXCatalyst Pharmaceuticals$21.63-1.9%4.8604 of 5 stars3.11$32.25 49.1%94.24%ARGXargenx$644.48-0.5%2.4952 of 5 stars2.86$658.39 2.2%22News CoveragePositive News4.22%ALKSAlkermes$35.33-0.5%3.6795 of 5 stars2.82$38.36 8.6%114.20%PTCTPTC Therapeutics$50.69+0.6%3.5944 of 5 stars2.47$58.85 16.1%15Analyst ForecastNews Coverage3.94%BHVNBiohaven$36.90-7.2%3.3961 of 5 stars3.07$63.15 71.1%15Short Interest ↓Positive News3.86%IARTIntegra LifeSciences$21.13-4.1%2.5468 of 5 stars1.75$23.00 8.8%83.79%NBIXNeurocrine Biosciences$120.69+3.9%4.9803 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up3.73%XENEXenon Pharmaceuticals$39.73+0.9%2.7079 of 5 stars3.11$57.38 44.4%9Options VolumeNews Coverage3.67%BIIBBiogen$140.64+2.6%4.7368 of 5 stars2.43$213.33 51.7%30Analyst Forecast3.55%SRPTSarepta Therapeutics$106.28-2.0%4.4955 of 5 stars2.87$176.77 66.3%23Upcoming EarningsPositive News3.53%SRRKScholar Rock$37.70-3.7%3.0408 of 5 stars3.14$40.43 7.2%7Insider TradeNews Coverage3.33%EWTXEdgewise Therapeutics$27.07-0.1%1.8167 of 5 stars2.86$41.29 52.5%73.30%PRAXPraxis Precision Medicines$74.49-6.3%1.7904 of 5 stars2.90$145.20 94.9%101.90%DYNDyne Therapeutics$14.01+0.1%3.0787 of 5 stars3.08$49.91 256.2%131.80%AVDLAvadel Pharmaceuticals$8.41-0.7%3.8495 of 5 stars3.00$19.88 136.3%81.65%AXGNAxoGen$18.00-2.7%1.0485 of 5 stars3.00$18.33 1.9%3News Coverage1.55%AVXLAnavex Life Sciences$8.35-3.8%3.7812 of 5 stars3.33$44.00 426.9%3Analyst ForecastAnalyst RevisionGap Up1.40%PRTAProthena$15.56+2.0%3.1215 of 5 stars2.71$45.83 194.6%7Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume1.22%CAPRCapricor Therapeutics$15.00-1.0%1.7258 of 5 stars3.00$34.50 130.0%61.02%DNTHDianthus Therapeutics$23.67-0.1%1.7604 of 5 stars3.22$46.83 97.9%90.96%CLPTClearPoint Neuro$16.72-4.2%1.8869 of 5 stars3.00$19.67 17.6%3News Coverage0.91%ZVRAZevra Therapeutics$7.68-1.9%2.0266 of 5 stars3.25$21.71 182.7%8Positive News0.65%NGNENeurogene$17.36+0.3%2.2505 of 5 stars3.13$60.83 250.4%80.63%ANNXAnnexon$2.81-0.7%2.5526 of 5 stars3.00$15.80 462.3%6News Coverage0.62%RAPPRapport Therapeutics$12.68-2.5%1.6238 of 5 stars3.00$35.00 176.0%3Upcoming Earnings0.60%TRDAEntrada Therapeutics$13.04-0.2%3.3031 of 5 stars3.25$25.67 96.8%4Positive News0.59%VNDAVanda Pharmaceuticals$4.43-1.3%4.0986 of 5 stars3.00$16.50 272.5%2Analyst ForecastAnalyst Revision0.56%TSHATaysha Gene Therapies$1.61-1.8%1.9274 of 5 stars3.00$6.63 311.5%80.52%SGMOSangamo Therapeutics$1.07-4.5%1.8713 of 5 stars2.67$5.17 382.9%60.51%ABEOAbeona Therapeutics$5.78-0.7%4.1992 of 5 stars3.00$18.00 211.4%3Analyst ForecastNews Coverage0.46%NVRONevro$5.74+0.1%1.8741 of 5 stars1.92$6.43 12.0%13Analyst Forecast0.43%VYGRVoyager Therapeutics$4.22-0.9%4.5204 of 5 stars3.11$15.72 272.4%9Upcoming EarningsNews Coverage0.33%AMLXAmylyx Pharmaceuticals$3.30-6.3%2.5413 of 5 stars2.56$7.33 122.2%90.28%ALECAlector$1.87+0.5%4.0507 of 5 stars2.14$3.75 100.5%7Gap Up0.26%LRMRLarimar Therapeutics$3.19-2.4%1.568 of 5 stars3.09$20.13 530.9%110.25%CTNMContineum Therapeutics$7.59-3.9%2.919 of 5 stars3.20$29.25 285.4%5News CoveragePositive News0.24%SLDBSolid Biosciences$5.78-3.7%4.0548 of 5 stars3.31$15.40 166.4%13Analyst ForecastAnalyst RevisionNews CoverageGap Up0.22%SAVACassava Sciences$2.55-5.6%3.7652 of 5 stars2.50$111.50 4,272.5%2Gap Up This page (NYSEARCA:IBRN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
